SCHEMBL2224948

SCHEMBL2224948

NS(=O)(=O)c1ccc(OCCC(F)(F)F)c(CNc2cc(Nc3ccc(Cl)cc3)ncn2)c1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TNNI3K Q59H18 11/20 0.51
LMNA P02545 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
ALDH1A1 P00352 1/20 0.45
CDK1 P06493 1/20 0.45
CCNB1 P14635 1/20 0.45
CCNA2 P20248 1/20 0.45
CCNE1 P24864 1/20 0.45
CDK2 P24941 1/20 0.45
CDK5 Q00535 1/20 0.45
CDK5R1 Q15078 1/20 0.45
MAPT P10636 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
STAT3 P40763 1/20 0.44
EGFR P00533 2/20 0.43
ERBB3 P21860 2/20 0.43
ABL1 P00519 2/20 0.42
BCR P11274 2/20 0.42
BRAF P15056 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2228424 0.91 TNNI3K (0.61) TNNI3KLMNASMN1; SMN2ALDH1A1CDK1
SCHEMBL2226278 0.88 TNNI3K (0.52) TNNI3KLMNASMN1; SMN2ALDH1A1CDK1
SCHEMBL2225574 0.88 TNNI3K (0.59) TNNI3KLMNASMN1; SMN2ALDH1A1CDK1
SCHEMBL2227311 0.85 TNNI3K (0.61) TNNI3KLMNACDK1CCNB1CCNA2
SCHEMBL2226458 0.84 TNNI3K (0.49) TNNI3KLMNASMN1; SMN2ALDH1A1CDK1
SCHEMBL2228373 0.84 TNNI3K (0.48) TNNI3KLMNASMN1; SMN2ALDH1A1CDK1
SCHEMBL2226058 0.83 TNNI3K (0.49) TNNI3KLMNASMN1; SMN2ALDH1A1CDK1
SCHEMBL2225463 0.82 CDK1 (0.47) TNNI3KCDK1CCNB1CCNA2CCNE1
Trifluoroacetic Acid SCHEMBL2226717 0.81 TNNI3K (0.47) TNNI3KLMNASMN1; SMN2ALDH1A1CDK1
SCHEMBL2226257 0.81 TNNI3K (0.49) TNNI3KLMNASMN1; SMN2ALDH1A1CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2523559-A1 COMPOUNDS AND METHODS GlaxoSmithKline LLC (US) 2012-11-21 EP claimed
WO-2011088027-A1 COMPOUNDS AND METHODS GLAXOSMITHKLINE LLC (US) 2011-07-21 WO claimed
EP-2523559-A1 COMPOUNDS AND METHODS GlaxoSmithKline LLC (US) 2012-11-21 EP disclosed
WO-2011088027-A1 COMPOUNDS AND METHODS GLAXOSMITHKLINE LLC (US) 2011-07-21 WO disclosed